Showing results (111-120 of 287) with videos related to
Sort By:
Pageof 29
Deutsche Medizinische Wochenschrift (1946)|September 16, 2004
[Chronic eosinophilic pneumonia]M Voss, M Allewelt, H LodeCritical Care Clinics|February 4, 1998
Nosocomial pneumonia in the critical care unitH M Lode, T Schaberg, M Raffenberg, et al.Respiratory Medicine|August 18, 2009
Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in GermanyR Diel, T Schaberg, R Loddenkemper, et al.Pneumologie (Stuttgart, Germany)|October 25, 2013
[Informations and recommendations of the German Respiratory Society and the Paul-Ehrlich-Society for chemotherapy concerning the outbreak of influenza A(H7N9) virus infections in humans]G Höffken, P Kern, U Buchholz, et al.Chemotherapy|January 1, 1982
Kinetic in vitro studies of antibacterial effects of the combination of new penicillins and cefalosporins against Proteus vulgarisA Dalhoff, A E Gehl, H LodeArzneimittel-Forschung|January 1, 1983
[Effect of doxycycline and isoconazole nitrate on human intestinal fungal flora]G Höffken, H Lode, H J KesslerDeutsche Medizinische Wochenschrift (1946)|August 22, 2001
[Respiratory filters and pneumonia: many unresolved questions]P Gastmeier, K D Beck, H LodeDeutsche Medizinische Wochenschrift (1946)|February 2, 2012
[Is monotherapy with β-lactam antibiotics still up to date? New aspects for treatment of severe infections]P Heizmann, H Lode, W R HeizmannThe American Journal of Physiology|December 1, 1994
Surfactant protein A modulates release of reactive oxygen species from alveolar macrophagesS Weissbach, A Neuendank, M Pettersson, et al.Clinical Drug Investigation|February 6, 2007
Real-life treatment of acute exacerbations of chronic bronchitis with moxifloxacin or macrolides: a comparative post-marketing surveillance study in general practiceT Schaberg, M Möller, T File, et al.Pageof 29